People · Operator

Matthew W. Kalnik, PhD

Named in public records as an officer, director or promoter · active 2017–2017 · Biotechnology

1
Companies
2
Filings
$632K
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Antidote Therapeutics, Inc.—BiotechnologyPre-Seed$632K$23.9M2017
Operator network

Matthew W. Kalnik, PhD at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Kenneth C Carter · 4 companies · 1 sharedKenneth C CarterAntidote Therapeutics, Inc. · $0.6M raisedAntidote Therapeutics…Matthew W. Kalnik, PhDMP
Matthew W. Kalnik, PhD Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Matthew W. Kalnik, PhD on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Kenneth C Carter14

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.